<?xml version="1.0" encoding="UTF-8"?>
<p>The protective effect of withaferin A on the integrity of red blood cells was evaluated in dimethylbenzanthracene induced oral carcinogenesis by measuring glycol-conjugates, red blood cell osmotic fragility, and membrane-bounded enzymatic activity. It was disclosed that oral administration of withaferin-A (20 mg/kg of body weight) for 14 weeks barred tumor incidence in the golden hamster completely (
 <xref rid="B193" ref-type="bibr">193</xref>).
</p>
